Author Question: Assess Mrs. Caldwell's height and weight. Calculate her BMI and her usual body weight. How would ... (Read 70 times)

lindiwe

  • Hero Member
  • *****
  • Posts: 577
Assess Mrs. Caldwell's height and weight. Calculate her BMI and her  usual body weight. How would edema affect your interpretation of this information? Using the KDOQI guidelines, what is Mrs. Caldwell's adjusted body weight?
 
  What will be an ideal response?

Question 2

Evaluate Mr. Campbell's initial nursing assessment. What important factors noted in his nutrition assessment may support the diagnosis of malnutrition?
 
  What will be an ideal response?



sarajane1989

  • Sr. Member
  • ****
  • Posts: 296
Answer to Question 1

Height: 157.4 cm, weight: 77.1 kg, UBW: 74 kg
BMI: 31.1 (per 77.1 kg weight)
UBW: 104
Edema certainly may account for the change from UBW.
SBW (medium frame) = 61 kg
Adjusted body weight = edema-free body weight + (standard BW- edema-free BW)  0.25 = 74 + (61 - 74)  0.25 = 70.75 kg

Answer to Question 2

 abdominal appearance: flat
 palpation of abdomen: soft
 dry skin
 tenting skin turgor
 skin condition: ecchymosis, dry, tearing
 mucous membranes: dry, petechiae



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library